Stay updated on Pirfenidone in COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Pirfenidone in COVID-19 Clinical Trial page.

Latest updates to the Pirfenidone in COVID-19 Clinical Trial page
- ChecktodayChange DetectedA sitewide banner announces an NIH website transition and says that content may use “Super Intelligence” instead of “Artificial Intelligence” during the change.SummaryDifference1%

- Check7 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1. The study page continues to display a 403 error.SummaryDifference0.2%

- Check35 days agoChange DetectedA 403 Forbidden page now appears for this study record, replacing the usual content and removing sections such as results, publications, and contact details. The page shows a minimal header and a 403 message, indicating access restrictions.SummaryDifference18%

- Check56 days agoChange DetectedThe page revision was updated to v3.6.6, replacing the previous v3.6.5, indicating a new version of the page and reflecting metadata changes rather than modifications to study data.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.6.5 replaces v3.6.4 on the page, indicating a small backend or template update. There are no evident changes to the study information or layout based on the provided diffs and screenshots.SummaryDifference0.1%

Stay in the know with updates to Pirfenidone in COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pirfenidone in COVID-19 Clinical Trial page.